Kinnate Biopharma Stock Technical Analysis
KNTEDelisted Stock | USD 2.96 0.27 8.36% |
As of the 25th of November, Kinnate Biopharma secures the Risk Adjusted Performance of 0.0046, standard deviation of 5.59, and Mean Deviation of 4.52. Kinnate Biopharma technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kinnate Biopharma information ratio and potential upside to decide if Kinnate Biopharma is priced some-what accurately, providing market reflects its recent price of 2.96 per share. Please also check out Kinnate Biopharma jensen alpha, which is currently at 0.1616 to check the company can sustain itself at a future point.
Kinnate Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Kinnate, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to KinnateKinnate |
Kinnate Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Kinnate Biopharma Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Kinnate Biopharma Trend Analysis
Use this graph to draw trend lines for Kinnate Biopharma. You can use it to identify possible trend reversals for Kinnate Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Kinnate Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Kinnate Biopharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Kinnate Biopharma applied against its price change over selected period. The best fit line has a slop of 0.0052 , which may suggest that Kinnate Biopharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1.04, which is the sum of squared deviations for the predicted Kinnate Biopharma price change compared to its average price change.About Kinnate Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Kinnate Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Kinnate Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Kinnate Biopharma price pattern first instead of the macroeconomic environment surrounding Kinnate Biopharma. By analyzing Kinnate Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Kinnate Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Kinnate Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Kinnate Biopharma November 25, 2024 Technical Indicators
Most technical analysis of Kinnate help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Kinnate from various momentum indicators to cycle indicators. When you analyze Kinnate charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0046 | |||
Market Risk Adjusted Performance | 0.0336 | |||
Mean Deviation | 4.52 | |||
Coefficient Of Variation | (19,184) | |||
Standard Deviation | 5.59 | |||
Variance | 31.27 | |||
Information Ratio | (0.03) | |||
Jensen Alpha | 0.1616 | |||
Total Risk Alpha | (0.92) | |||
Treynor Ratio | 0.0236 | |||
Maximum Drawdown | 22.4 | |||
Value At Risk | (9.14) | |||
Potential Upside | 8.7 | |||
Skewness | 0.1575 | |||
Kurtosis | (0.21) |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Kinnate Stock
If you are still planning to invest in Kinnate Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kinnate Biopharma's history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |